Stevanato's Q4 Adjusted Earnings Decline, Revenue Increases; 2026 Outlook Initiated
MT Newswires Live
Mar 04
Stevanato (STVN) reported Q4 adjusted earnings Wednesday of 0.18 euro per diluted share, down from 0.19 euros a year earlier.
Analysts polled by FactSet expected 0.17 euro.
Revenue for the quarter ended Dec. 31 was 346.5 million euros, up from 330.6 million euros a year earlier.
Analysts surveyed by FactSet expected 333.1 million euros.
For 2026, the pharmaceutical services and supply company expects adjusted EPS of 0.59 euro to 0.63 euro and revenue of 1.26 billion euros to 1.29 billion euros.
Analysts surveyed by FactSet expect 0.63 euro and 1.28 billion euros, respectively.
Shares of the company were up 5.1% in recent premarket activity.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.